🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

12+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 12 of 12 recruiting trials for “neuroendocrine-cell-hyperplasia-of-infancy”

Phase 2RecruitingNCT06202066 ↗

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

👨‍⚕️ Jasmeet Kaur, MD, Roswell Park Cancer Institute📍 1 site📅 Started Apr 2026View details ↗
Phase 2RecruitingNCT06471556 ↗

Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study

👨‍⚕️ Nadia NATHAN, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT06282016 ↗

Risk Factors for Neuroendocrine Neoplasms

👨‍⚕️ Jacqueline Müller-Nordhorn, Bavarian Cancer Registry, Bavarian Health and Food Safety Authority📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT07077551 ↗

NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06276309 ↗

Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

👨‍⚕️ Pengming Sun, PhD, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University📍 9 sites📅 Started Feb 2024View details ↗
Phase 3RecruitingNCT05918302 ↗

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

👨‍⚕️ Jaume Capdevila, M.D. Ph.D., Hospital Vall d'Hebron📍 27 sites📅 Started Oct 2023View details ↗
RecruitingNCT06402695 ↗

Observational Study on GEP-and Pulm-NET Treated at FPG

👨‍⚕️ Giovanni Schinzari, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT05879055 ↗

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN

👨‍⚕️ Jianming Xu, Chinese PLA General Hospital📍 13 sites📅 Started May 2023View details ↗
RecruitingNCT06337760 ↗

YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.

👨‍⚕️ Francesca Spada, MD, Istituto Europeo di Oncologia📍 1 site📅 Started Mar 2023View details ↗
NARecruitingNCT06523582 ↗

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

👨‍⚕️ Laura C Hernández Ramírez, MD, PhD, Universidad Nacional Autonoma de Mexico📍 3 sites📅 Started Aug 2022View details ↗
NARecruitingNCT06279299 ↗

Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision

👨‍⚕️ Haitao Zhou, National Cancer Center, China📍 1 site📅 Started Aug 2022View details ↗
Phase 2RecruitingNCT04893785 ↗

A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)

🏥 National Cancer Institute, Naples📍 1 site📅 Started Jun 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →